<DOC>
	<DOCNO>NCT00541216</DOCNO>
	<brief_summary>Previous research demonstrate possible efficacy Ephedrine treatment congenital myasthenia cause end-plate acetylcholinesterase deficiency . The aim current study test hypothesis Ephedrine may beneficial patient . To test hypothesis perform double blind , placebo-controlled , crossover study clinical efficacy safety study . Drug na√Øve patient agree participate randomize two group . Each group treat blind manner 5 week either placebo Ephedrine HCl escalate dose 100 mg per day divide two dos . After five week group cross continue treatment placebo five week . Evaluations strength fatiguability do baseline , end five week period two week . Safety assess weekly investigator use interview physical examination . Outcome measure include Barthel index , Quality life questionnaire , Timed go , spirometry , time elevation limb , force measurement . All patient report clinic per study schedule ( See Appendix A ) . Specifically , 12 clinic visit include : baseline ( 1 ) , safety efficacy assessment ( 10 ) closeout ( 1 ) .</brief_summary>
	<brief_title>Ephedrine Treatment Congenital Myasthenia</brief_title>
	<detailed_description />
	<mesh_term>Lambert-Eaton Myasthenic Syndrome</mesh_term>
	<mesh_term>Myasthenic Syndromes , Congenital</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<criteria>Male female patient , congenital myasthenia , belong previously report kindred diagnosed COLQ deficiency . History allergy Ephedrine inactive component . Significant abnormality screen Cardiovascular parameter ( blood pressure , pulse ) . Surgery within 6 week screen . Concurrent use medication except steroid . Pregnancy . Thyrotoxicosis . Comorbid condition neurological disorder would confound assessment clinical parameter . Participation another clinical trial within 30 day study start . Patients noncooperative parents/ legal guardian unwilling sign consent form .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>congenital myasthenia</keyword>
	<keyword>ephedrine</keyword>
</DOC>